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Key messages 
 
o There is increasing interest in the development of interventions that in resource 
poor settings combine health with economic and social development initiatives 
such as microfinance 
 
o Not much evidence currently exists of the economic viability of these types of 
initiatives 
 
o This study evaluated a combined microfinance and gender training intervention 
for the prevention of intimate partner violence in rural South Africa. It was found 
to be cost-effective in pilot phase and highly cost-effective in scale-up 
 
o This study suggests that proven development initiatives such as microfinance 
represent ideal vehicles for value-adding public health interventions and that 
some form of public subsidy to support and strengthen their use in such roles is 
warranted. 
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Abstract 
 
Objective: Assess the cost-effectiveness of an intervention combining microfinance with 
gender and HIV training for the prevention of intimate partner violence (IPV) in South 
Africa.  
 
Methods: We did a cost-effectiveness analysis alongside a cluster-randomised trial. We 
assessed the cost-effectiveness of the intervention in both the trial and initial scale up 
phase 
 
Results: We estimated the cost per DALY gained as $7,688 for the trial phase and 
$2,307 for the initial scale-up. The findings were sensitive to the statistical uncertainty in 
effect estimates but otherwise robust to other key assumptions employed in the analysis. 
 
Conclusions: The findings suggest that this combined economic and health intervention 
was cost-effective in its trial phase and highly cost-effective in scale-up. These estimates 
are probably conservative, as they do not include the health and development benefits of 
the intervention beyond IPV reduction  
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Economic evaluation of a combined microfinance and gender training intervention 
for the prevention of intimate partner violence in rural South Africa 
 
Introduction 
 
As in many other settings globally, physical and sexual violence against women in South 
Africa is a major challenge, with recent estimates suggesting nearly 25% of ever-
partnered women report having been in an abusive relationship (Jewkes, Levin et al. 
2002). In addition to being an abuse of women’s rights, intimate partner violence is 
increasingly recognised as a neglected but important public health problem, with 
significant impacts on women’s physical, reproductive and sexual, and mental health 
(Campbell 2002; Garcia-Moreno 2006). The development of cost-effective interventions 
to prevent IPV and that are appropriate and relevant to resource poor settings remains 
an urgent priority. 
 
The Intervention with Microfinance for AIDS & Gender Equity (IMAGE) administered a 
package that combined microfinance with a participatory gender and HIV training 
curriculum to rural women in Limpopo Province, South Africa. Effects of the intervention 
were assessed using a cluster-randomised trial between 2001 and 2004. Effect 
estimates suggest that, relative to a matched comparison group, IMAGE participants 
experienced a 55% (9%;77%) reduction in the past year experience of physical and/or 
sexual violence by an intimate partner (IPV) (Pronyk, Hargreaves et al. 2006).   
 
The microfinance (MF) component of the intervention offered access to group-based 
credit and savings services, using a Grameen Bank model, (Yunus 1999) where five 
women formed a solidarity group to collectively guarantee one another’s loans. Forty 
women constituted a ‘loan centre’ which met fortnightly to repay loans and discuss 
financial matters. The programme was administered by Small Enterprise Foundation 
(SEF, Tzaneen, South Africa) and was poverty focused – targeting the poorest 
households in each village identified through participatory wealth ranking techniques 
(Hargreaves, Morison et al. 2007). Loans were used for income generation, with the 
most common types of businesses being buying and selling fruit and vegetables (54%), 
making/selling clothing (23%), food stalls (8%), and running small spaza shopsa (5%). 
                                                 
a
 These are small shops in the local village that sell a wide variety of products, ranging from bread and soft-drinks to small 
household wares.  
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The original study was conducted in an area that  had no prior exposure to microfinance. 
Upon completion of the study, the combined intervention was rolled-out to control 
villages and the wider local area, affording the opportunity for assessing the costs 
associated with taking the intervention to scale.. 
 
The gender and HIV training component of the intervention was called Sisters for Life 
(SfL) and was implemented in each loan centre over a 12-15 month period. The 
curriculum was developed and piloted by a local and expatriate team over six months 
preceding its full implementation and evaluation. A key feature of this type of intervention 
was the upfront investment in capacity building. The SfL training curriculum comprised 
two phases (RADAR 2002). In phase 1, participants engaged in 10 one-hour training 
and discussion sessions at the beginning of compulsory fortnightly meetings. The 
training sessions used adult education techniques to address issues such as gender 
roles, cultural beliefs, relationships, communication, IPV and HIV.  In phase 2, those 
women identified by their peers as natural leaders were involved in an intensive one-
week leadership training workshop. Upon returning to their communities, they in turn 
facilitated the development of village-level action plans geared towards individual and 
collective mobilisation around common concerns. These activities were repeated in the 
scaling up of the intervention following the completion of the trial. 
 
Many health problems, including IPV, are deeply rooted in social and economic 
vulnerabilities. Proponents for integrating economic and health interventions argue that 
such packages provide both the means (income) and the knowledge (empowerment) to 
improve household well-being, and may serve as a stimulus for wider mobilisation 
around pervasive public health problems(UNDP 1999; Pronyk 2008). Combined 
approaches such as IMAGE provide an incentive for individuals to participate in public 
health programs, which in the absence of loans, they likely would not. Furthermore, 
microfinance institutions contain an element of financial sustainability and, with 100 
million clients worldwide (Daley-Harris 2006), also work towards economies of scale – 
both critical for cost-effective interventions aimed at changing complex and deeply-
rooted social norms (McDonagh 2001).  Operational research into cost-effective models 
of delivering public health interventions in resource poor settings that are both 
sustainable and scaleable remains at an early stage.  
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In this paper, we assessed the cost-effectiveness of the IMAGE intervention in relation to 
its effect on IPV. As the microfinance component of the intervention package was 
financially sustainable and thus cost neutralb, we examined the incremental costs of 
integrating the training curriculum, alongside IPV-related outcomes and Disability 
Adjusted Life Years (DALYs). This enabled an assessment as to whether the type of 
activities incorporated in the approach can feasibly be built into the business models of 
microfinance organisations and importantly, whether such programs merit the allocation 
of scarce public funding through some form of subsidy. Finally, as access to the 
intervention in the post-trial period was substantially expanded and efforts were made to 
institutionalise the intervention within communities, we also examined the costs and 
cost-effectiveness of scale-up. In short, we hypothesise whether this intervention is cost-
effective and whether this varies as the intervention is scaled up. 
 
Methods 
 
Trial costs were measured over the duration of the trial period during which the 
combined intervention package was delivered to 855 clients in four target villages. IPV 
outcomes were assessed after 2 years of intervention exposure. Costs associated with 
the scale-up were based on observed costs over the initial two years following the trial, 
and involved an additional 2598 clients. On the basis of the primary outcome of the trial, 
the costs of the intervention per additional woman free of IPV for the previous 12 months 
were estimated for both the trial and scale-up. These results were then transformed, on 
the basis of demographic (Statistics South Africa 2006) and burden of disease data from 
South Africa(Norman, Bradshaw et al. 2007; Norman, Bradshaw et al. 2009), into 
estimates of costs per DALY averted to enable a general assessment of cost-
effectiveness. The cost-effectiveness of IMAGE in the trial phase was thus estimated 
separately from the initial 2 years of scale-up. 
 
Costs 
The costing adopted an ingredients approach (Creese and Parker 1994) based on the 
financial statements of the program and host microfinance organisation. All costs were 
adjusted for local consumer price index increases and reported in 2004 US dollar prices 
                                                 
b
 Repayment rates by the end of the trial phase in the IMAGE sites were 99.7% and the host microfinance organisation, 
the Small Enterprise Foundation, was financially and operationally sustainable (expenses met by interest on loans).  
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(US$1 = 6.45 ZAR). A provider perspective was adopted, and the costs to participants 
and families were not included in this analysis (e.g. travel and opportunity costs of 
attending meetings). A 3% discount rate was used throughout, as recommended by the 
World Health Organization (Edejer, Baltussen et al. 2003). 
 
All items of capital (office space, equipment, vehicles) were assigned a current 
market/replacement value based on national South African prices at the base year (e.g. 
the estimated local prevailing market rent for office space) and cost allocated to the 
intervention on the basis of estimated use. The equipment entailed two laptop computers 
and there were three vehicles used to varying degrees during the course of the 
intervention.  
 
Personnel costs were valued either at prevailing gross salary in the relevant year or – for 
volunteer labour – at the market rates for equally qualified personnel occupying 
equivalent positions, reflecting their economic cost(Drummond, O'Brien et al. 1997).  The 
personnel included 3 SfL trainers, 1 facilitator, and two external consultants in the initial 
trial phase – a project director and a senior trainer. Other recurrent costs included 
supplies (mainly stationery), transport (public transport), operations (photocopier lease, 
furniture and telephone) and maintenance (vehicles and building). 
 
Costs associated with adherence to the research protocol were excluded(Drummond, 
O'Brien et al. 1997; Glick, Doshi et al. 2007). These were incurred because the sites 
chosen for the intervention were located substantially farther apart than would normally 
be the case due to random village assignment. Adjustments to transport costs were 
therefore made by assuming the use of public transport by local staff in line with program 
operations in a non-research setting. 
 
A major component of costs was the initial development costs associated with training of 
staff and production of training materials. As it was expected that the initial investment in 
these activities would yield benefits beyond the duration of the study, such costs were 
annuitised (Creese and Parker 1994; Jan, Pronyk et al. 2008). Initial staff training was 
annuitised over 5 years, while conceptualisation of the protocol and production of the SfL 
training manuals was annuitised over 10 years to reflect their potential for use not only in 
scale-up but in other settings,, in view of previous experience with similar materials in 
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other African contexts. Factored into these costs were the consultancy services that 
were required for the planning of the initial intervention and in the training of staff and 
volunteers.  
 
At the commencement of scale-up, further training was undertaken to enable expansion 
of the program. Major new inputs were the training and deployment of additional 
facilitators. Each trainer was responsible for nine loan centres, in line with standard 
practice for the microfinance partner. The cost of this training was annuitised in line with 
the approach used at the outset of the trial. Overall, the analysis of scale-up costs 
employed similar assumptions and methods as for the trial.  
 
Effectiveness  
The effectiveness of the intervention in terms of reduction in the risk of past year IPV as 
observed in the trial was assumed to apply to both the trial and the scale-up. Scale-up 
entailed the expansion of the intervention to populations in surrounding districts where 
we assumed the integrity and quality of the intervention was well-maintained. We would 
expect no difference in baseline characteristics between such similarly treatment-naïve 
trial and scale-up populations to thus suggest any difference in absolute effect.  
 
 
The transformation of the primary trial outcome into DALYs is outlined in table 1. It was 
based on recent burden of disease estimates of DALYs to IPV in South Africa in which 
the DALYs due to IPV was estimated at 319,135. This was derived through identifying a 
set of sequelae associated with IPV (depression, anxiety, alcohol consumption, drug 
abuse, self harm, smoking, cervical cancer, HIV/AIDS, sexually transmitted disease, 
femicides and injury), the DALYs associated with each condition and then weighting 
these by their population attributable fraction to IPV. (Norman, Bradshaw et al. 2007; 
Norman, Bradshaw et al. 2009), By utilising population data (Statistics South Africa 
2006) and IPV prevalence estimates, we were then able to determine that for each case 
of a woman reporting an experience of IPV in the previous 12 months, on average, there 
was a resulting burden of 0.0923 DALYs. Given the potential error in the estimate of this 
parameter, it was tested in sensitivity analysis. 
 
Insert table 1  
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Sensitivity analysis was conducted in relation to the following parameters:  
• the upper and lower bound confidence limits of the effect estimates from the trial 
(Pronyk, Hargreaves et al. 2006) 
• varying the DALY value of an incident case of IPV by + and – 20%  
• increasing the expected life of investment in staff training to 10 years 
• decreasing the expected life of investment in protocol development and training 
manuals to 5 years; and 
• varying the discount rate to 0% and 6% (Edejer, Baltussen et al. 2003). 
 
Results 
 
Development costs 
Table 2 sets out the development costs. These included the costs of training and training 
material development incurred initially, at the outset of the trial, and the further training 
costs at the commencement of the scale-up.   
 
Insert table 2 
 
The initial training costs were $61,115, the costs of training material development were 
$13,877, and further training costs at scale-up were $57,663. A significant component of 
the development costs at the initiation of the trial were consultant fees paid to overseas 
experts; these were not incurred in the scale-up since the training in the latter phase was 
carried out by local program staff. 
 
 
Cost-effectiveness 
Table 3 reports a breakdown of cost figures for the duration of the trial and initial scale-
up and cost-effectiveness estimates.   
 
Insert table 3 
 
Over the two-year trial period, the cost of SfL training was $36,706. In total, 855 clients 
participated in the intervention, with total per client costs equal to $42.93. During the 
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initial scale-up, the total cost to reach an additional 2,598 clients was $33,467, with a 
cost per client of $12.88. 
 
When set against effect estimates from the trial, cost-effectiveness ratios for the trial and 
the scale-up phase were $710 and $213 per woman per IPV-free year gained 
respectively. On the basis of the transformation outlined in table 1, these equate to 
$7,688 and $2,307 per DALY averted. 
   
Sensitivity analysis 
The sensitivity analysis in table 4 indicates:   
• some uncertainty in relation to the effect estimates – a consequence of the 
limited number of clusters enrolled in the trial, resulting in wide confidence 
intervals for most indicators. For the trial, the cost per DALY averted ranged from 
$5,491 to $46,982; whilst for initial scale-up, it ranged from $1,648 to $14,099. 
• the results were fairly robust in relation to the other parameters. Varying these 
results in cost-effectiveness between $5,015 to $9,610 for the trial phase and 
$1,454 and $2,884 for the initial scale-up. 
 
Insert table 4 
 
 
Discussion 
 
The IMAGE intervention combined group-based microfinance with a gender and HIV 
training program. During the trial period, the intervention reached 855 women in 12 loan 
centres from four study villages. The incremental cost of delivering the intervention 
during this phase was $36,706, or $42.93 per client. An assessment of the costs of 
taking this to scale within the local area showed that at two years, with coverage 
extended to a further 2,598 clients, there was a reduction in average costs to $12.88 per 
client. This indicates that substantial improvements in cost-effectiveness could be 
achieved with scaling-up due to a larger number of clients, and the move from an 
expatriate supported training programme to the provision of training by local staff.  
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Within study villages, effect estimates suggest that levels of IPV would be reduced by 
55%, at an estimated cost-effectiveness of $7,688 per DALY averted in the trial phase 
and $2,307 per DALY averted in the initial 2 years of scale-up. There is little basis for 
direct comparison of these impact results as this was the first randomised controlled trial 
in a developing country study to demonstrate significant reductions in levels of IPV. 
There were however a number of pragmatic features in the original trial particularly in the 
design of the intervention that provide confidence that its findings could be sustained 
particularly in the scale up phase. For example:  
• the development of the SfL curriculum was developed through an extensive 
phase of consultation based on participatory learning and principles and thus was 
tailored to the specific concerns of the community. aside from initial input into the 
training and development of materials, the intervention was staffed largely 
through use of local staff whose skill profile increased over time.the intervention 
built onto locally established formal and informal institutions (such as the SEF, 
the existing social groupings on which the loan groups were configured and the 
leadership provided by key women in these groups) and utilised existing facilities 
made available by the local health service. 
 
These design elements were important in embedding the intervention through engaging 
directly with community members and opportunistically capitalising on existing 
community resources. A number of secondary outcomes reported in the trial give some 
confidence that this process had been successful - there was the initiation of various 
activities in the intervention sites including 40 village workshops, 16 meetings with 
leaderships structures, five marches, two partnerships with local institutions and the 
formation of two new village committees (Pronyk 2006).  
 
Violence clearly has a number of potential ‘down-stream’ consequences – from loss of 
life, physical disability and hospitalisation, to HIV infection(Dunkle, Jewkes et al. 2005), 
and emotional and psychological conditions including depression and anxiety. Data on 
savings to the health sector or to other agencies such as the police associated with 
these reductions in IPV were not collected. While inclusion of such data would further 
support the case for cost-effectiveness, access to health or social support for survivors 
of intimate partner violence remains a serious obstacle in this population(McIntyre and 
Gilson 2002). Nevertheless, generating estimates of disability-adjusted-life year (DALYs) 
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attributable to IPV enabled the broader implications of violence for the health sector to 
be factored into the assessment of outcomes in the economic evaluation, and facilitate 
comparisons of cost-effectiveness with other potential areas of health investment. 
 
The World Health Organization generalised benchmark for cost-effectiveness is that a 
cost per DALY averted of less than 3 times the gross domestic product per capita (GDP) 
is deemed ‘cost-effective’; and that a cost per DALY averted of less than the GDP per 
capita is deemed ‘highly cost-effective’(World Health Organization). In 2004, the GDP 
per capita in South Africa was $4,666 (World Bank 2005). Thus subject to some 
uncertainty around the effect estimates, the IMAGE intervention achieves cost-
effectiveness in its trial phase and is highly cost-effective when scaled-up.  
 
Additionally, it needs to be recognised that complex structural interventions such as 
IMAGE have the potential to influence multiple health and social outcomes.  In such 
cases, cost-effectiveness might be more appropriately assessed through a cost-
consequences analysis in which the full range of benefits of the intervention are 
acknowledged(Drummond, O'Brien et al. 1997; Coast J. 2004; Jan, Pronyk et al. 2008). 
In the trial, it was established that the intervention reduced poverty, led to positive shifts 
in social capital and multiple indicators of empowerment, and resulted in lower levels of 
HIV risk behaviour among young women who received the intervention(Pronyk, 
Hargreaves et al. 2006; Kim JC, Watts C et al. 2007; Pronyk 2008; Pronyk PM, Kim et al. 
2008). As such, the cost per DALY averted estimates presented here, that are based 
solely on reductions in IPV are likely to underestimate the true value of the intervention.  
 
There are also potential limitations to our estimates that are important to underscore. 
First, the distinction between research-driven costs and operational costs were at times 
complex to disentangle. Close collaboration with the teams involved was crucial for the 
identification of the resources devoted to each activity, and of the rationale to 
discriminate operational and research-driven features of the trial period. Second, recall 
bias on the part of project staff had the potential to interfere with the accuracy of our 
assessment. However, we feel the adoption of a micro-costing approach yielded a very 
accurate assessment of resources used for the trial and initial phase of the scale-up. In 
addition, triangulation of data sources was used to check consistency, including multiple 
members of staff asked to relate the process of the intervention, the same pieces of 
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information being collected from different individuals, and the information that individuals 
reported being checked against financial records where relevant. 
 
Cost-effective interventions for the prevention of IPV in resource-poor settings are 
critically important, yet the evidence base to facilitate policy and program development 
remains at an early stage. This study indicates that coupling financial services to skills 
building and education may provide an important opportunity for addressing IPV. 
Additional research attempting to disentangle the effects of the microfinance and training 
from microfinance alone suggests that only the combined approach led to consistent 
improvement in health and social outcomes – highlighting the potential synergies that 
are important to underscore. Emerging evidence from the microfinance sector suggests 
such integrated approaches may lead to additional health benefits – including 
improvements in breast-feeding, diarrhoea management, immunisation rates, and the 
nutritional status of children (Marcus, Porter et al. 1999; Dunford 2001; Morduch and 
Haley 2001; Pronyk PM, Hargreaves JR et al. 2007). This study suggests that proven 
development initiatives such as microfinance represent ideal opportunities for such 
value-adding public health interventions and that some form of public subsidy to support 
and strengthen these is warranted. 
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 Table 1: Transforming IPV-free year gained to DALYs averted 
 
 
1. Absolute number of DALYs due to IPV in South Africa(Norman, 
Bradshaw et al. 2009) 
 
319,135 
 
2. Population females >15 years(Statistics South Africa 2006) 
 
18,784,600 
 
3. Prevalence of women >15 years reporting IPV in past 12 
months(Norman, Bradshaw et al. 2009) 
 
18.4% 
 
4. Number of women >15 years reporting IPV in past 12 months in South 
Africa (2x3) 
 
3,456,366 
 
5. DALYs / woman experiencing IPV past 12 months (1/4) 
 
0.0923 
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Table 2:  Development costs  
 
 
Training costs at commencement of trial  
 
$ 
 Buildings  918 
 Equipment  861 
 Consultancies (non-recurrent)  21,031 
 Vehicles  6,181 
 
 
 Personnel  26,311 
 Supplies  419 
 Transport  3,528 
 Vehicle operating and maintenance  1,568 
 Building operating and maintenance  338 
 
Total Costs 
 
61,155 
 
Annuitised training costs - trial     
 
26,707 
 
Training materials development 
 
 Buildings  62 
 Equipment  65 
 Consultancies (non-recurrent)  11,657 
 Vehicles  215 
  
 Personnel  1,581 
 Supplies  28 
 Transport  201 
 Vehicle operating and maintenance  54 
 Building operating and maintenance  14 
 
 Total Costs  
 
13,877 
 
Annuitised training materials development costs 
 
3,254 
 
Training costs at commencement of scale-up 
 
 Personnel  51,507 
 Supplies  252 
 Transport  4,913 
 Vehicle operating and maintenance  825 
 Building operating and maintenance  167 
  
Total Costs  
 
57,663 
 
Annuitised training costs – scale-up     
 
13,520 
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Table 3: Cost-effectiveness estimates of trial and scale-up operations 
 
Costs 
 
Trial 
 
Scale-up 
Fixed 
  
 
Buildings 
 
$110 
 
$110 
 
Equipment 
 
$115 
 
$115 
 
Vehicles 
 
$150 
 
$3,281 
 
Development costs c 
     Training - trial    
 
 
$26,707 
 
  
$26,707 
  
      Manuals 
 
$3,254 
 
$3,254 
 
      Training – scale-upd  
  
$13,520 
 
Variable 
  
Operational staffe $5,429  
 
Suppliesd 
 
$52 
 
 
Transportd 
 
$425 
 
 
Vehicle operating and maintenanced 
 
$37 
 
 
Building operating and maintenanced 
 
$32 
 
 
TOTAL COSTS 
 
$36,706 
 
$33,467 
 
Per Capita Cost 
 
$42.93 
 
$12.88 
 
Baseline risk of IPV in previous 12 months 
 
11% 
 
11% 
 
Relative risk reduction (effect estimate from trial) 
 
55% 
 
55% 
 
Absolute risk reduction  
 
6.05% 
 
6.05% 
 
Cost per woman with an IPV–free year gained  
 
$710 
 
$213 
 
DALY / woman experiencing IPV past 12 monthsf  
 
0.0923 
 
0.0923 
 
Cost per DALY averted 
 
 
$7,688 
 
$2,307 
                                                 
c
 See table 2 
d
  The costs are fixed within the scale up phase  
e
 These were costs involved in establishing the operations (as opposed to the development and 
training) and  incurred only the trial phase  
f
 See table 1 
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Table 4: Sensitivity analysis – cost per DALY averted 
 
 
Parameter 
 
Trial 
$ 
 
Scale-up 
$ 
 
Upper bound 77% relative risk reduction  5,491 1,648 
 
Low bound 9% relative risk reduction 
 
46,982 14,099 
Upper bound DALY value of an incident IPV (+20%) 6,407 1,923 
 
Lower bound DALY value of an incident IPV (-20%) 
 
 
9,610 
 
2,884 
Expected life (5 yrs; 5 yrs) 
 
Expected life (10yrs; 10 yrs) 
 
Discount rate 0% 
 
Discount rate 6% 
8,193 
 
5,015 
 
7,053 
 
8,184 
2,501 
 
1,454 
 
2,119 
 
2,437 
   
 
 
 
